ArticleCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions2026
Retrograde Balloon Pulmonary Angioplasty for Otherwise Uncrossable Lesions in Chronic Thromboembolic Pulmonary Hypertension.
Article in Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBalloon pulmonary angioplasty (BPA) is an established treatment for chronic thromboembolic pulmonary hypertension (CTEPH). However, some totally occlusive lesions remain uncrossable with conventional antegrade BPA because the proximal entry of the occlusion cannot be identified angiographically.
aimsTo evaluate the outcomes of transcollateral retrograde BPA for lesions that are not amenable to antegrade recanalization.
methodsWe retrospectively investigated the procedural outcomes of 30 lesions in 19 patients treated with transcollateral retrograde BPA at our institution between April 2016 and December 2025. All lesions were either uncrossable with a guidewire despite antegrade attempts or had an indistinct proximal end of the occlusion, precluding identification of a safe antegrade entry point despite angiographic and intravascular imaging assessment. Procedural success was defined as successful balloon dilation restoring antegrade flow. Procedure-related complications were defined as hemoptysis, respiratory deterioration requiring positive-pressure ventilation, or procedure-related death.
resultsProcedural success was achieved in 15 of 30 lesions (50%). When divided into three sequential groups of 10 lesions each, success rates were 50%, 30%, and 70%, respectively. Mild hemoptysis occurred in 3 cases (10%), whereas severe complications or death did not occur. Causes of procedural failure included inability to cross the collateral channel (12 cases) and failure to penetrate the occlusion (3 cases). Difficult collateral channels were characterized by severe tortuosity, small vessel diameter, and capillary-like connections.
conclusionsTranscollateral retrograde BPA may enable recanalization of otherwise untreatable occlusive pulmonary artery lesions with an acceptable safety profile.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.